GLP-1 Second Opinion Consultation | Internal Medicine

A GLP-1 second opinion is an independent review of weight-loss or diabetes treatment you are already on, by a doctor who did not prescribe it. At Karespot it is a ₹799 online consultation with an NMC-registered Internal Medicine specialist who reads your prescription and history in advance, then tells you whether your current medicine, dose and plan are appropriate, and what they would change.

You receive the opinion in writing. You are free to take it back to your existing doctor, act on it with us, or do nothing at all.

The most common reasons are: you were prescribed and then not reviewed again, you are being told to push through persistent side effects, your weight has plateaued, you are unsure whether you are on the right brand or paying a fair price, you have a condition such as thyroid disease, PMOS (PCOS) or retinopathy that nobody asked about, or you are thinking about stopping.

You do not need something to have gone wrong. Wanting a second set of eyes is reason enough.

No. Our doctors are salaried clinicians and receive no commission for moving you to Karespot or for recommending any particular brand, and a meaningful share of second opinions conclude that the patient's existing plan is appropriate.

If your current treatment is sound, the doctor will say so, and you will have paid ₹799 for the reassurance. That is a legitimate outcome, not a failed consultation.

Yes. That is what this consultation is for. It does not matter whether your prescription came from a hospital, a clinic, another online provider or a general physician.

You do not need permission from your current doctor, and we do not contact them unless you ask us to.

Your current prescription or a photo of the pack, any recent blood work such as HbA1c, thyroid or lipid profile, and a short note on what is worrying you. A list of any other medicines and supplements you take is useful too.

If you do not have reports, that is fine. Send what you have and your doctor will tell you on the call whether anything else is worth testing.

It can recommend a change, and if you choose to act on it with Karespot, your doctor can issue a fresh prescription where that is clinically appropriate.

Since the Indian semaglutide patent expired in March 2026, the same molecule is sold under many brand names at very different prices, so brand and cost are now a routine part of these reviews. Any change to your dose is a medical decision, never something to adjust on your own.

Yes. Registered medical practitioners in India may consult patients remotely, and second opinions are an established part of medical practice. GLP-1 medicines are Schedule H, prescription-only, so any prescription arising from the consultation is issued by a registered doctor after assessing you individually.

Every Karespot prescriber holds MBBS and MD (Internal Medicine) and is registered with the National Medical Commission and their State Medical Council. Their registration numbers are published on this page.

Then you carry on with confidence, and you have a written record saying an independent specialist reviewed it. Many people find that more valuable than a change.

Your doctor will still usually give you something practical: how to manage a side effect better, what to watch for, or when your next review should be.

Yes, and it is often the best time. A second opinion before your first injection can confirm whether you meet the criteria, whether the proposed medicine and starting dose are right, and what the realistic outcome looks like for someone with your history.

If you have never been assessed by any doctor for GLP-1 treatment, the ₹599 first consultation is the right starting point instead.

Yes. ₹799 covers the review of your records, the consultation itself and the written summary afterwards. There is no registration fee, no subscription and no obligation to buy medication or join a programme.

If you later decide to start treatment with Karespot, the cost of medication and the support programme is shown transparently before you commit to anything.

Everything you share is treated as confidential clinical information and is seen only by your reviewing doctor and the clinical team supporting your case. We do not contact your existing prescriber unless you specifically ask us to.

Consultations are held online by video or phone, so there is no clinic waiting room and nothing arrives at your address unless you choose to start treatment.